ArticleFrontiers in cardiovascular medicine2026
Impact of a combined care ambulatory and home-based aerobic exercise program using wearables on anxiety and depression in patients with metabolic syndrome.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05592704 (The Development and Application of a Toolset for Monitoring Personalized Physical Activity and Evaluation of Its Effectiveness in Individuals With Metabolic Syndrome), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Development and Application of a Toolset for Monitoring Personalized Physical Activity and Evaluation of Its Effectiveness in Individuals With Metabolic Syndrome
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anxiety and depressive symptoms are more common in individuals with metabolic syndrome (MetS), which is characterized by abdominal obesity, subclinical atherosclerosis, and impaired glucose metabolism. Although aerobic exercise training (aET) with direct medical staff supervision improves cardiometabolic health, its implementation remains limited in this population. Technology-assisted physical activity (PA) interventions may enhance adherence, but their impact on mental health in MetS is not well established. Therefore, the aim of this study was to evaluate whether a supervised ambulatory aET program followed by a device-supported home-based aET program improves anxiety and depression levels in individuals with MetS. Methods: In this prospective study (NCT05592704), 132 adults with MetS (mean age 52.4 ± 6.3 years; 54.6% female) completed a 2-month supervised ambulatory aET program (40 min, 5 days/week). Participants were then randomized to: (1) a control group receiving only standard PA recommendations for 6 months, or (2) a intervention group receiving an individualized 6-month home-based aET program supported by the dedicated smartphone application and a Polar H10 heart-rate monitor. Anxiety and depression were assessed at baseline, after 2 and 8 months using the Hospital Anxiety and Depression Scale. Results: Linear Mixed Model analysis revealed significant Group × Time interactions for anxiety ( Conclusion: A 2-month supervised ambulatory aET program followed by a 6-month home-based aET program with remote supervision using wearables significantly reduced both anxiety and depression levels in individuals with MetS. These findings demonstrate that combined care aET models not only initiate symptom reduction but also facilitate the long-term maintenance of mental health gains, highlighting the potential of technology-assisted interventions to enhance psychological outcomes in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.